Chemical Compound

Rifampicin

CAS Registry Number 13292-46-1

Back to search Request a Quote

Primary Record

Rifampicin

In stock: 6,355 g
Purity: 99.0 %
CAS: 13292-46-1

Compound Identifiers & Properties

CAS: 13292-46-1
PubChem CID: 135398735
SMILES: C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
Canonical SMILES: CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

Names & Synonyms

Rifampicin
rifampin
Rifadin
Rimactane
Rimactan
Rifaldazine
Rifaprodin
Rifoldin
Rifa
Rifampicinum
Rifamycin AMP
Riforal
Rifoldine
Rifaldin
Abrifam
Eremfat
Tubocin
Ramp
Rifampicina
Rifampicine
Rimactizid
Archidyn
Rifadine
Rifagen
Rimazid
Benemicin
Doloresum
Fenampicin
Rifaldazin
Rimactazid
Rifampicin SV
Rifapiam
Sinerdol
Arficin
Rifamor
Rifinah
Rifobac
Arzide
Rifcin
Rifam
L-5103 Lepetit
Benemycin
Rifater
R/AMP
13292-46-1
null
rifamcin
Rifamsolin
Rifamate
Dione 21-acetate
Dipicin
Rimycin
Famcin
Rimactane;
Mixture Name
Rifampicin RS
Rifadin Iv
Rifadin;
Rifampicin 1g
Rifampicin CRS
Rifampicine [French]
Rifamicin AMP
Rifampin [USAN]
Rifadin I.V.
Rifadin I.V
Rimactane (TN)
Rifampin/Rifampicin
Rifampin (USP)
Rifampicin & EEP
Prestwick_833
Rifadin (TN)
R-Cin
RIFAMYCIN
VJT6J7R4TR
Rifampicinum [INN-Latin]
Ba 41166/E
Rifampicina [INN-Spanish]
Piperine & Rifampicin
Rifampicin & Propolis
Rifampicin (Standard)
Rifampin (Rifampicin)
Reserpine & Rifampicin
Rifadin IV NOVAPLUS
L-5103-LEPETIT
CCRIS 551
RefChem:55979
RIFAMPIN [HSDB]
Rifampin [USAN:USP]
Unable to generate value
RIFAMPIN [MI]
RIFAMPICIN [INN]
RIFAMPICIN [JAN]
RIFAMPIN [VANDF]
Prestwick2_000525
Prestwick3_000525
Spectrum5_002018
UNII-VJT6J7R4TR
RIFAMPICIN [IARC]
Rifampicin [INN:BAN:JAN]
BA-41166E
DTXSID6021244
Rifampicin (JP18/INN)
HSDB 3181
C43H58N4O12
RIFAMPICIN [MART.]
RIFAMYCIN AMP [MI]
JQXXHWHPUNPDRT-WLSIYKJHSA-N
NSC-113926
RIFAMPICIN [WHO-DD]
RIFAMPICIN [WHO-IP]
NSC113926
SCHEMBL23490
BSPBio_000509
CHEBI:28077
NIH-10782
RIFAMPIN [ORANGE BOOK]
8CI)
BPBio1_000561
CHEMBL374478
DTXCID301244
GTPL2765
Rifampicin, 98% - 5G 5g
BA-41166/E
RIFAMPICIN [EP IMPURITY]
RIFAMPIN [USP MONOGRAPH]
SCHEMBL22517710
SCHEMBL29400640
EINECS 236-312-0
ERK5-2G11
HY-B0272R
RIFATER COMPONENT RIFAMPIN
J04AB02
RIFAMPICIN [EP MONOGRAPH]
MFCD00151389
RIFAMATE COMPONENT RIFAMPIN
HMS1569J11
HMS2089F12
HMS2096J11
HMS3713J11
L-5103
NSC 113926
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
DRG-0109
MSK10166
Rifampicin, >=97.0% (HPLC)
RIFAMPICINUM [WHO-IP LATIN]
Rifampicin, powder, gamma-irradiated
Ba 41166
BBF-04562
BDBM50370232
GR-306
MMV688775
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
AKOS015951372
Rifampicin - CAS 13292-46-1
Rifampicin, >=97% (HPLC), powder
AR11351
BA 411661E
CCG-208267
DB01045
LS-7689
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00022678-06
1,25(29),26-octaen-13-yl acetate
BC205696
M880
SID:53790678
ST057531
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
CID:135398735
AB1009526
Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-
NS00011698
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
8-(n-(4-methyl-1-piperazinyl)formidoyl)-rifomycins
C06688
D00211
J10110
Rifampicin, VETRANAL(TM), analytical standard
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
AB00383022_07
292R461
A899126
D012293
Q422652
SR-05000002118
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
RFP
SR-05000002118-3
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
3-[[(4-Methyl-1-piperazinyl)imino]methyl]-rifamycin
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
RIF
3-(((4-METHYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN
Rifampicin, European Pharmacopoeia (EP) Reference Standard
Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate
Rifampin, United States Pharmacopeia (USP) Reference Standard
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate
Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material
yclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,2
4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate
Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline
yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-
((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-(4-methylpiperazin-1-yl)iminomethyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(4-methylpiperazin-1-yliminomethyl)-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-21-yl acetate
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac
(2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-15,17,27,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-(4-methylpiperazin-4-ium-1-yl)iminomethyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-2-olate
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11- methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino] methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1 (28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-((E)-((4-methylpiperazin-1-yl)imino)methyl)-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.1(4,7).0(5,28))triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-N-(4-methylpiperazin-1-yl)carboximidoyl]-6,23-dioxo-8,30-dioxa-24-azatetrac
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methyl-1-piperazinyl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyc
(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-(((4-methylpiperazin-1-yl)imino)methyl)-6-oxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate
[pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate
2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (
236-312-0
26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)-naphtho[2,1-b]furan-1,11(2 H)-dione 21-acetate
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate
6998-60-3
845504-52-1
Rf
Rifampicin in combination with actinonin, BB-3497, hydroxylamine hydrochloride, and 1,10-phenanthroline
Rifampicin; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate; Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-; -(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate (8CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate (7CI); 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.; 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV; 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,
RIP
RMP
Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate